Table 3.
Variable | Levels | Acceptance (%) | Hesitancy (%) | Univariable OR (CI) | Multivariable OR (CI) |
---|---|---|---|---|---|
Age | <30 | 813 (26.8) | 2220 (73.2) | − | − |
30–39 | 460 (27.9) | 1189 (72.1) | 0.95 (0.83–1.08) | 1.21 (1.03–1.42) | |
40–49 | 178 (25.7) | 514 (74.3) | 1.06 (0.88–1.28) | 1.41 (1.14–1.75) | |
50–59 | 52 (19.9) | 209 (80.1) | 1.47 (1.08–2.03) | 1.92 (1.37–2.73) | |
>59 | 19 (26.0) | 54 (74.0) | 1.04 (0.62–1.81) | 1.62 (0.93–2.94) | |
Chronic Diseases | No | 1321 (26.9) | 3587 (73.1) | − | − |
Yes | 201 (25.1) | 599 (74.9) | 1.10 (0.93-1.31) | 1.01 (0.84–1.22) | |
Country | Arab countries | 1289 (25.8) | 3707 (74.2) | − | − |
Other countries | 233 (32.7) | 479 (67.3) | 0.71 (0.60–0.85) | 0.87 (0.73-1.05) | |
Academic Education | Higher education | 1045 (27.0) | 2830 (73.0) | − | − |
Lower education | 477 (26.0) | 1356 (74.0) | 1.05 (0.93–1.19) | 0.97 (0.84–1.14) | |
Had Covid | No | 754 (29.2) | 1825 (70.8) | − | − |
Not sure | 468 (25.2) | 1391 (74.8) | 1.23 (1.07-1.41) | 1.25 (1.08–1.44) | |
Yes | 300 (23.6) | 970 (76.4) | 1.34 (1.15–1.56) | 1.34 (1.14-1.58) | |
Gender | Male | 1049 (33.1) | 2122 (66.9) | − | − |
Female | 473 (18.6) | 2064 (81.4) | 2.16 (1.91–2.44) | 2.04 (1.79–2.32) | |
Vaccine Type Unknown | No | 1173 (30.4) | 2684 (69.6) | − | − |
Yes | 349 (18.9) | 1502 (81.1) | 1.88 (1.64–2.16) | 1.69 (1.47–1.96) | |
Influenza Vaccine | Yearly | 178 (55.5) | 143 (44.5) | − | − |
Some years | 279 (41.0) | 402 (59.0) | 1.79 (1.37–2.35) | 1.70 (1.29–2.24) | |
Rarely | 210 (29.5) | 502 (70.5) | 2.98 (2.27–3.91) | 2.87 (2.17–3.81) | |
Never | 855 (21.4) | 3139 (78.6) | 4.57 (3.62–5.77) | 4.30 (3.37–5.49) |